Literature DB >> 31239558

ACMG response to Nussbaum et al. letter on ACMG policy statement: the use of secondary findings recommendations for general population screening: a policy statement of the ACMG.

.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31239558     DOI： 10.1038/s41436-019-0573-3

Source DB:  PubMed          Journal:  Genet Med        ISSN： 1098-3600            Impact factor:   8.822


× No keyword cloud information.
  4 in total

1.  Commentary on ICH guideline on genomic sampling and data management-enabling opportunities in drug development and patient treatment.

Authors:  Falk Ehmann; Jeroen Aerssens; Rebecca Blanchard
Journal:  Br J Clin Pharmacol       Date:  2020-05-18       Impact factor: 4.335

2.  Primary Care Implementation of Genomic Population Health Screening Using a Large Gene Sequencing Panel.

Authors:  Robert S Wildin; Christine A Giummo; Aaron W Reiter; Thomas C Peterson; Debra G B Leonard
Journal:  Front Genet       Date:  2022-04-25       Impact factor: 4.772

3.  Frequency of ClinVar Pathogenic Variants in Chronic Kidney Disease Patients Surveyed for Return of Research Results at a Cleveland Public Hospital.

Authors:  Dana C Crawford; John Lin; Jessica N Cooke Bailey; Tyler Kinzy; John R Sedor; John F O'Toole; William S Bush
Journal:  Pac Symp Biocomput       Date:  2020

4.  Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic Cardiomyopathy.

Authors:  Antonio de Marvao; Kathryn A McGurk; Sean L Zheng; Marjola Thanaj; Wenjia Bai; Jinming Duan; Carlo Biffi; Francesco Mazzarotto; Ben Statton; Timothy J W Dawes; Nicolò Savioli; Brian P Halliday; Xiao Xu; Rachel J Buchan; A John Baksi; Marina Quinlan; Paweł Tokarczuk; Upasana Tayal; Catherine Francis; Nicola Whiffin; Pantazis I Theotokis; Xiaolei Zhang; Mikyung Jang; Alaine Berry; Antonis Pantazis; Paul J R Barton; Daniel Rueckert; Sanjay K Prasad; Roddy Walsh; Carolyn Y Ho; Stuart A Cook; James S Ware; Declan P O'Regan
Journal:  J Am Coll Cardiol       Date:  2021-09-14       Impact factor: 24.094
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.